Bookmark and Share

2010 Radiation Oncology Mentors & Projects

Projects Research Area Preceptor
Preclinical evaluation of Rad50 inhibitors as radiosensitizers Radiobiology Alan Tomkinson, PhD 
Chemopotentiation of low-dose fractionated radiation therapy in lymphomas Radiobiology France Carrier, PhD 
Radiosensitizing effect of Histone Deacetylase Inhibitors for the treatment of GBM with LDFRT in combination with RT Radiobiology France Carrier, PhD 
Participate in critical evaluation of the cancer elimination properties of DNA ligase inhibitors in the process of drug discovery and novel cancer therapeutic development Radiobiology Helen Xi Chen, PhD
 
Elucidate the molecular mechanism of human RS (radiosensitive)-SCID (severe combined immunodeficiency) syndrome and the pathways that suppress the symptoms Radiobiology Helen Xi Chen, PhD
 
Therapeutic strategies in chronic myeloid leukemia with resistance to tyrosine kinase inhibitors use of PARP and DNA ligase inhibitors Radiobiology Fey Rassool, PhD 
Mechanism(s) for DNA damage caused by chromatin modifying agents, such as histone deacetylase inhibitors in myeloid malignancies Radiobiology Fey Rassool, PhD 
Mechanism(s) for genomic instability in AML with FLT3/ITD mutations Radiobiology Fey Rassool, PhD 
DNA damage and repair capacity as mechanism(s) for genomic instability in hematopoietic stem cells, leukemic stem cells and embryonic stem cells Radiobiology Fey Rassool, PhD 
Preclinical evaluation of DNA ligase inhibitors as novel anti cancer agents Radiobiology Alan Tomkinson, PhD 
University of Maryland experience with GKRS for radio-resistant histologies +/- whole brain radiotherapy Clinical William Regine, MD / Young Kwok, MD 
Preclinical evaluation of PARP inhibitors as low-dose radiation sensitizers in brain cancer Radiobiology
 
Elizabeth Kubiczek, PhD
 
4D Treatment Planning Physics Warren D'Souza, PhD